8,8-DIFLUORO-5,6,7,8-TETRAHYDRO-1,6-NAPHTHYRIDINE-5,7-DIONE, 95.0%, 1g

4-{5-[(2S)-2-pyrrolidinyl]-1,2,4-oxadiazol-3-yl}pyridine dihydrochloride, 95.0%, 1g

3-Methylsulfolane>98.0%(GC)25g

1,2-dimethyl-1H-imidazole-5-carbaldehyde, 95.0%, 250mg

6-AMINO-9H-PURINE-8-THIOL, 95.0%, 100mg

Boc-(+/-)-Phosphonoglycine trimethyl ester, 98.0%, 10g

(3aS,3a'S,7aS,7a'S)-2,2'-(((2S,4S)-Pentane-2,4-diyl)bis(oxy))bis(1,3-diphenyloctahydro-1H-benzo[d][1,3,2]diazaphosphole), 98%, 100mg

1H-Pyrrolo[3,2-b]pyridin-2(3H)-one, 95.0%, 100mg

2-Chloro-N-(2,3-dihydroxypropyl)acetamide, 95.0%, 1g

1-(tert-Butoxycarbonyl)indoline-7-carboxylic acid, 95.0%, 10g

GC capillary column ROTI®Cap-1, 50 m, 0.20 mm, 0.35 µm, 1 Piece(s)

2-Acetoxybenzoic anhydride, 95.0%, 250mg

(2E)-1-{[1,1'-biphenyl]-4-yl}-3-(4-ethylphenyl)prop-2-en-1-one, 95.0%, 2g